Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy
- PMID: 25502014
- DOI: 10.1007/s12928-014-0310-4
Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy
Abstract
Percutaneous transluminal septal myocardial ablation (PTSMA) has been widely accepted as a therapeutic option for patients with hypertrophic obstructive cardiomyopathy (HOCM). To achieve success in PTSMA, we need to explore the target septal arteries, including any anomalous branches that feed the hypertrophic septal myocardium causing left ventricular outflow tract obstruction. An HOCM case in which PTSMA was performed through a dominant right superior septal (RSS) artery is presented. In cases without an effective septal branch artery arising from the left anterior descending artery, an RSS artery should be sought as an alternative route for PTSMA.
Keywords: Coronary artery anomaly; Hypertrophic obstructive cardiomyopathy; Percutaneous transluminal septal myocardial ablation.
Similar articles
-
Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.Heart Vessels. 2017 Nov;32(11):1320-1326. doi: 10.1007/s00380-017-0997-0. Epub 2017 May 29. Heart Vessels. 2017. PMID: 28555387
-
[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].Zhonghua Nei Ke Za Zhi. 2006 Mar;45(3):210-2. Zhonghua Nei Ke Za Zhi. 2006. PMID: 16624154 Chinese.
-
Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.Int J Cardiol. 2006 Sep 10;112(1):80-4. doi: 10.1016/j.ijcard.2005.10.009. Epub 2006 Feb 28. Int J Cardiol. 2006. PMID: 16507323
-
Percutaneous transluminal septal myocardial ablation: past, present, and future.J Cardiol. 2022 Sep;80(3):211-217. doi: 10.1016/j.jjcc.2021.11.023. Epub 2021 Dec 16. J Cardiol. 2022. PMID: 34924238 Review.
-
Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard.Expert Rev Cardiovasc Ther. 2008 Jun;6(5):715-22. doi: 10.1586/14779072.6.5.715. Expert Rev Cardiovasc Ther. 2008. PMID: 18510487 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical